Skip to main content

Anti-β2-glycoprotein I in Sjogren’s syndrome is associated with parkinsonism

Clinical Rheumatology volume 26, pages 743–747 (2007)Cite this article

Abstract

The nervous system may be involved in up to 30% of patients with Sjogren’s syndrome (SS). We describe three patients with Sjogren’s syndrome and a concomitant parkinsonian syndrome. Elevated titers of anti-β2-glycoprotein I IgG were found in the serum of all three patients. This autoantibody is strongly associated with anticardiolipin (aCL) antibodies, antiphospholipid syndrome (APS), and thromboembolic phenomena, but its role in the pathogenesis of the parkinsonian disorder in SS is unclear. These patients may present a subtype of SS patients in which the presence of aCL antibodies is associated with central nervous system involvement predominantly in the basal ganglia.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Alexander E (1992) Central nervous system disease in Sjogren’s syndrome. New insights into immunopathogenesis. Rheum Dis Clin North Am 18(3):637–672

    PubMed  CAS  Google Scholar 

  2. Nishimura H, Tachibana H, Makiura N, Okuda B, Sugita M (1994) Corticosteroid-responsive parkinsonism associated with primary Sjogren’s syndrome. Clin Neurol Neurosurg 96(4):327–331

    PubMed  Article  CAS  Google Scholar 

  3. Creange A, Sedel F, Brugieres P, Voisin MC, Degos JD (1997) Primary Sjogren’s syndrome presenting as progressive parkinsonian syndrome. Mov Disord 12(1):121–123

    PubMed  Article  CAS  Google Scholar 

  4. Fabre N, Faucheux J, Roland Y, Cantagrel A, Geraud G (1996) Corticosteroid-responsive parkinsonism associated with primary Sjogren’s syndrome: Report of two cases (abstract). Neurology 46:A299

    Google Scholar 

  5. Hashimoto S, Sawada T, Inoue T, Yamamoto K, Iwata M (1999) Cholinergic-drug induced sicca syndrome in Parkinson’s disease: a case report and a review of the literature. Clin Neurol Neurosurg 101(4):268–270

    PubMed  Article  CAS  Google Scholar 

  6. Miyoshi Y, Atsumi T, Kitagawa H, Ogura N, Amasaki Y, Tsutsumi A et al (1993) Parkinson-like symptoms as a manifestation of systemic lupus erythematosus. Lupus 2(3):199–201

    PubMed  CAS  Google Scholar 

  7. Walker RH, Spiera H, Brin MF, Olanow CW (1999) Parkinsonism associated with Sjogren’s syndrome: three cases and a review of the literature. Mov Disord 14(2):262–268

    PubMed  Article  CAS  Google Scholar 

  8. Visser LH, Koudstaal PJ, van de Merwe JP (1993) Hemiparkinsonism in a patient with primary Sjogren’s syndrome. A case report and a review of the literature. Clin Neurol Neurosurg 95(2):141–145

    PubMed  Article  CAS  Google Scholar 

  9. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY et al (1996) Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicenter study. The European Study Group on Diagnostic Criteria for Sjogren’s Syndrome. Ann Rheum Dis 55(2):116–121

    PubMed  CAS  Google Scholar 

  10. Alexander EL (1993) Neurologic disease in Sjogren’s syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 19(4):869–908

    PubMed  CAS  Google Scholar 

  11. Greco TP, Amos MD, Conti-Kelly AM, Naranjo JD, Ijdo JW (2000) Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I. Lupus 9(1):33–41

    PubMed  Article  CAS  Google Scholar 

  12. Osawa H, Yamabe H, Kaizuka M, Tamura N, Tsunoda S, Shirato KI et al (1997) Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms. Lupus 6(7):613–615

    PubMed  CAS  Google Scholar 

  13. Mochizuki H, Okano M, Masaki T, Nagata N, Kamakura K (1997) A case of Sjogren’s syndrome with a high titer of anticardiolipin antibody that developed as parkinsonism. Rinsho Shinkeigaku 37(1):57–59

    PubMed  CAS  Google Scholar 

  14. Shahar E, Goshen E, Tauber Z, Lahat E (1998) Parkinsonian syndrome complicating systemic lupus erythematosus. Pediatr Neurol 18(5):456–458

    PubMed  Article  CAS  Google Scholar 

  15. Inanc M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S et al (1998) Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 37(10):1089–1094

    PubMed  Article  CAS  Google Scholar 

  16. Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP (1996) The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 101(6):576–583

    PubMed  Article  CAS  Google Scholar 

  17. Pennec YL, Magadur G, Jouquan J, Youinou P (1991) Serial measurements of anticardiolipin antibodies in primary Sjogren’s syndrome. Clin Exp Rheumatol 9(2):165–167

    PubMed  CAS  Google Scholar 

  18. Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Munoz FJ et al (1997) Antiphospholipid antibodies in primary Sjogren’s syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 15(4):361–365

    PubMed  CAS  Google Scholar 

  19. Jedryka-Goral A, Jagiello P, D’Cruz DP, Maldykowa H, Khamashta MA, Hughes GR et al (1992) Isotype profile and clinical relevance of anticardiolipin antibodies in Sjogren’s syndrome. Ann Rheum Dis 51(7):889–891

    PubMed  CAS  Google Scholar 

  20. Verrotti A, Cieri F, Pelliccia P, Morgese G, Chiarelli F (2000) Lack of association between antiphospholipid antibodies and migraine in children. Int J Clin Lab Res 30(2):109–111

    PubMed  Article  CAS  Google Scholar 

  21. Tietjen GE, Day M, Norris L, Aurora S, Halvorsen A, Schultz LR et al (1998) Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology 50(5):1433–1440

    PubMed  CAS  Google Scholar 

  22. Pal B, Gibson C, Passmore J, Griffiths ID, Dick WC (1989) A study of headaches and migraine in Sjogren’s syndrome and other rheumatic disorders. Ann Rheum Dis 48(4):312–316

    PubMed  CAS  Article  Google Scholar 

  23. Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Pini C et al (1998) Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun 11(5):425–429

    PubMed  Article  CAS  Google Scholar 

  24. Brunella C, Valerio P, Guido P, Guido V (1998) Anti-b -glycoprotein I antibodies bind to central nervous system. J Neurol Sci 156:211–219

    Article  Google Scholar 

  25. Shoenfeld Y, Nahum A, Korczyn AD, Dano M, Rabinowitz R, Beilin O, Pick CG, Leider-Trejo L, Kalashnikova L, Blank M, Chapman J (2003) Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12:436–442

    PubMed  Article  CAS  Google Scholar 

  26. Shrot S, Katzav A, Korczyn AD, Litvinjuk Y, Hershenson R, Pick CG, Blank M, Zaech J, Shoenfeld Y, Sirota P, Chapman J (2002) Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 11:736–743

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Neurology, Sackler Faculty of Medicine, Chaim Sheba Medical Center, Tel Aviv University, Tel-Hashomer, 52621, Tel-Aviv, Israel

    Sharon Hassin-Baer

  2. Department of Medicine E, Sackler Faculty of Medicine, Meir Medical Center, Tel Aviv University, KFAR SABA, 44281, Tel Aviv, Israel

    Yair Levy

  3. Department of Internal Medicine F, Sackler Faculty of Medicine, Chaim Sheba Medical Center, Tel Aviv University, Tel-Hashomer, 52621, Tel Aviv, Israel

    Pnina Langevitz

  4. Department of Family Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Sasson Nakar

  5. Department of Internal Medicine C, Sackler Faculty of Medicine, Chaim Sheba Medical Center, Tel Aviv University, Tel-Hashomer, 52621, Tel Aviv, Israel

    Michael Ehrenfeld

Authors
  1. Sharon Hassin-Baer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yair Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pnina Langevitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sasson Nakar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Ehrenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yair Levy.

Additional information

Sharon Hassin-Baer and Levy Yair contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hassin-Baer, S., Levy, Y., Langevitz, P. et al. Anti-β2-glycoprotein I in Sjogren’s syndrome is associated with parkinsonism. Clin Rheumatol 26, 743–747 (2007). https://doi.org/10.1007/s10067-006-0398-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0398-8

Keywords

  • Anti-β2-glycoprotein I
  • Anticardiolipin
  • Parkinsonism
  • Parkinson’s disease
  • Sjogren’s syndrome